Abstract
While many patients with hereditary optic neuropathies are caused by mitochondrial DNA (mtDNA) mutations of Leber’s hereditary optic neuropathy (LHON), a significant proportion of them does not have mtDNA mutation and is caused by mutations in genes of the nuclear genome. In this study, we investigated whether the OPA1 gene, which is a pathogenic gene for autosomal dominant optic atrophy (ADOA), is frequently mutated in these patients. We sequenced all 29 exons of the OPA1 gene in 105 Han Chinese patients with suspected LHON. mtDNA copy number was quantified in blood samples from patients with and without OPA1 mutation and compared to healthy controls. In silico program-affiliated prediction, evolutionary conservation analysis, and in vitro cellular assays were performed to show the potential pathogenicity of the mutations. We identified nine OPA1 mutations in eight patients; six of them are located in exons and three are located in splicing sites. Mutation c.1172T > G has not been reported before. When we combined our data with 193 reported Han Chinese patients with optic neuropathy and compared to the available data of 4327 East Asians by the Exome Aggregation Consortium (ExAC), we found a significant enrichment of potentially pathogenic OPA1 mutations in Chinese patients. Cellular assays for OPA1 mutants c.869G > A and c.2708_2711del showed abnormalities in OPA1 isoforms, mitochondrial morphology, and cellular reactive oxygen species (ROS) level. Our results indicated that screening OPA1 mutation is needed for clinical diagnosis of patients with suspected optic neuropathy.
Similar content being viewed by others
References
Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF (2009) Inherited mitochondrial optic neuropathies. J Med Genet 46(3):145–158
Hoppins S, Lackner L, Nunnari J (2007) The machines that divide and fuse mitochondria. Annu Rev Biochem 76:751–780
Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, Bartoli D, Polishuck RS et al (2006) OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126(1):177–189
Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P, Lenaers G (2003) Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 278(10):7743–7746
Kushnareva YE, Gerencser AA, Bossy B, Ju WK, White AD, Waggoner J, Ellisman MH, Perkins G et al (2013) Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity. Cell Death Differ 20(2):353–365
Wang AG, Fann MJ, Yu HY, Yen MY (2006) OPA1 expression in the human retina and optic nerve. Exp Eye Res 83(5):1171–1178
Yu-Wai-Man P, Shankar SP, Biousse V, Miller NR, Bean LJ, Coffee B, Hegde M, Newman NJ (2011) Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies. Ophthalmology 118(3):558–563
Zhang AM, Jia X, Bi R, Salas A, Li S, Xiao X, Wang P, Guo X et al (2011) Mitochondrial DNA haplogroup background affects LHON, but not suspected LHON, in Chinese patients. PLoS One 6(11), e27750
Feng YM, Jia YF, Su LY, Wang D, Lv L, Xu L, Yao YG (2013) Decreased mitochondrial DNA copy number in the hippocampus and peripheral blood during opiate addiction is mediated by autophagy and can be salvaged by melatonin. Autophagy 9(9):1395–1406
Bi R, Zhang AM, Zhang W, Kong QP, Wu BL, Yang XH, Wang D, Zou Y et al (2010) The acquisition of an inheritable 50-bp deletion in the human mtDNA control region does not affect the mtDNA copy number in peripheral blood cells. Hum Mutat 31(5):538–543
Bi R, Zhang W, Yu D, Li X, Wang HZ, Hu QX, Zhang C, Lu W et al (2015) Mitochondrial DNA haplogroup B5 confers genetic susceptibility to Alzheimer’s disease in Han Chinese. Neurobiol Aging 36(3):1604. e7
Guo H, Zhuang XY, Zhang AM, Zhang W, Yuan Y, Guo L, Yu D, Liu J et al (2012) Presence of mutation m.14484T > C in a Chinese family with maternally inherited essential hypertension but no expression of LHON. Biochim Biophys Acta 1822(10):1535–1543
Ferre M, Amati-Bonneau P, Tourmen Y, Malthiery Y, Reynier P (2005) eOPA1: an online database for OPA1 mutations. Hum Mutat 25(5):423–428
Ferre M, Caignard A, Milea D, Leruez S, Cassereau J, Chevrollier A, Amati-Bonneau P, Verny C et al (2015) Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data. Hum Mutat 36(1):20–25
Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Current protocols in human genetics/editorial board, Jonathan L Haines [et al.] Chapter 7:Unit7 20
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248–249
Chun S, Fay JC (2009) Identification of deleterious mutations within three human genomes. Genome Res 19(9):1553–1561
Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11(4):361–362
Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4(7):1073–1081
Ng PC, Henikoff S (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31(13):3812–3814
Chen Y, Jia X, Wang P, Xiao X, Li S, Guo X, Zhang Q (2013) Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy. Mol Vis 19:292–302
Elachouri G, Vidoni S, Zanna C, Pattyn A, Boukhaddaoui H, Gaget K, Yu-Wai-Man P, Gasparre G et al (2011) OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res 21(1):12–20
Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J et al (2000) Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26(2):207–210
Tonska K, Kodron A, Bartnik E (2010) Genotype-phenotype correlations in Leber hereditary optic neuropathy. Biochim Biophys Acta 1797(6–7):1119–1123
Chen J, Xu K, Zhang X, Jiang F, Liu L, Dong B, Ren Y, Li Y (2014) Mutation screening of mitochondrial DNA as well as OPA1 and OPA3 in a Chinese cohort with suspected hereditary optic atrophy. Invest Ophthalmol Vis Sci 55(10):6987–6995
Kamakari S, Koutsodontis G, Tsilimbaris M, Fitsios A, Chrousos G (2014) First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation. Mol Vis 20:691–703
Liskova P, Ulmanova O, Tesina P, Melsova H, Diblik P, Hansikova H, Tesarova M, Votruba M (2013) Novel OPA1 missense mutation in a family with optic atrophy and severe widespread neurological disorder. Acta Ophthalmol (Copenh) 91(3):e225–e231
Yu-Wai-Man P, Stewart JD, Hudson G, Andrews RM, Griffiths PG, Birch MK, Chinnery PF (2010) OPA1 increases the risk of normal but not high tension glaucoma. J Med Genet 47(2):120–125
Olichon A, Landes T, Arnaune-Pelloquin L, Emorine LJ, Mils V, Guichet A, Delettre C, Hamel C et al (2007) Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis. J Cell Physiol 211(2):423–430
Pesch UE, Leo-Kottler B, Mayer S, Jurklies B, Kellner U, Apfelstedt-Sylla E, Zrenner E, Alexander C et al (2001) OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance. Hum Mol Genet 10(13):1359–1368
Lodi R, Tonon C, Valentino ML, Iotti S, Clementi V, Malucelli E, Barboni P, Longanesi L et al (2004) Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. Ann Neurol 56(5):719–723
Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M, Toscano A, Musumeci O et al (2010) Multi-system neurological disease is common in patients with OPA1 mutations. Brain 133(Pt 3):771–786
Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, Nakayama K, Nakayama KI, Ide T et al (2006) Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 8(11):1291–1297
Brenner C, Galluzzi L, Kepp O, Kroemer G (2013) Decoding cell death signals in liver inflammation. J Hepatol 59(3):583–594
Tang S, Le PK, Tse S, Wallace DC, Huang T (2009) Heterozygous mutation of Opa1 in Drosophila shortens lifespan mediated through increased reactive oxygen species production. PLoS One 4(2), e4492
Yarosh W, Monserrate J, Tong JJ, Tse S, Le PK, Nguyen K, Brachmann CB, Wallace DC et al (2008) The molecular mechanisms of OPA1-mediated optic atrophy in Drosophila model and prospects for antioxidant treatment. PLoS Genet 4(1), e6
Chen L, Liu T, Tran A, Lu X, Tomilov AA, Davies V, Cortopassi G, Chiamvimonvat N et al (2012) OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction and mtDNA instability. J Am Heart Assoc 1(5), e003012
Sanderson TH, Raghunayakula S, Kumar R (2015) Release of mitochondrial Opa1 following oxidative stress in HT22 cells. Mol Cell Neurosci 64:116–122
Acknowledgments
We thank all participants in this study. We thank Miss Dandan Yu and Dr. Deng-Feng Zhang for the technical assistance. This study was supported by National Natural Science Foundation of China (grant number 81200725) and the Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB02020003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Written informed consents conforming to the tenets of the Declaration of Helsinki were obtained from each participant prior to the study. The Institutional Review Boards of the Zhongshan Ophthalmic Center and the Kunming Institute of Zoology approved this study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Table 1
(DOC 62 kb)
Supplementary Table 2
(DOC 35 kb)
Supplementary Table 3
(XLSX 26 kb)
Rights and permissions
About this article
Cite this article
Zhang, AM., Bi, R., Hu, QX. et al. The OPA1 Gene Mutations Are Frequent in Han Chinese Patients with Suspected Optic Neuropathy. Mol Neurobiol 54, 1622–1630 (2017). https://doi.org/10.1007/s12035-016-9771-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-016-9771-z